Each study has a usefulness score out of 100 (rubric version 4.0). Tap a score to see what makes it up.
Highest usefulness score first. Studies without a score come last.
-
Compared to CN counterparts, patients with MCI have higher proportion of families Sclerotiniaceae, Phaffomyceteceae, Trichocomaceae, Cystofilobasidiaceae, Togniniaceae and genera Botrytis, Kazachstania, Phaeoacremonium and Cladosporium and lower abundance of Meyerozyma.
-
Of 541 identified studies, 34 were included in the analysis.
-
-oxide (TMAO) is a small organic molecule, derived from the intestinal and hepatic metabolism of dietary choline and carnitine.
-
47/100
Alzheimer's disease is a complex neurodegenerative disorder leading to a decline in cognitive function and mental health.
-
The recent success of disease-modifying anti-amyloid monoclonal antibodies in slowing Alzheimer's disease (AD) symptoms has been an exciting step forward for the field.
-
47/100
Despite an ever-growing prevalence and increasing economic burden of Alzheimer's disease (AD) and Parkinson's disease (PD), recent advances in drug development have only resulted in minimally effective treatment.
-
The amount of time spent in poor health at the end of life is increasing.
-
The prefrontal cortex (PFC) serves as the chief executive officer of the brain, controlling the highest level cognitive and emotional processes.
-
47/100
Previous studies have identified a crucial role of the gut microbiome in modifying Alzheimer's disease (AD) progression.
-
Although there was no difference in the microbial α-diversity among the three groups, patients with AD or MCI had increased β-diversity compared with healthy controls.
-
Alzheimer's disease (AD), the most common form of dementia, is a leading cause of death and a major cause of morbidity in older people.
-
47/100
Defective brain hormonal signaling has been associated with Alzheimer's disease (AD), a disorder characterized by synapse and memory failure.
-
Alzheimer's disease (AD) is associated with cognitive dysfunction.
-
47/100
Activation of microglia by classical inflammatory mediators can convert astrocytes into a neurotoxic A1 phenotype in a variety of neurological diseases 1,2 .
-
Type 2 diabetes and hyperglycemia with the resulting increase of glucose concentrations in the brain impair the outcome of ischemic stroke, and may increase the risk of developing Alzheimer's disease (AD).
-
Multiple avenues of research including epidemiology, molecular genetics and cell biology have identified links between Parkinson's disease and type 2 diabetes mellitus.
-
Among the natural extracts tested, PanQ emerged as the most effective for increasing the active CatB isoform in correspondence with enhanced levels of synaptic proteins and the autophagy marker LC3-II.
-
As expected, males had higher lean mass and VO2peak than females (p = 0.01), but groups did not differ in body mass index (p = 0.51).
-
Despite recent advances, severe acute pancreatitis (SAP) remains a lethal inflammation with limited treatment options.
-
The pathway analysis of six major cell types revealed a strong association between APOE2 and cellular stress and energy metabolism, particularly in excitatory and inhibitory neurons, which was found to be more pronounced in the presence of beta-amyloid (Aβ).
-
A variety of potentially modifiable risk factors have been investigated in an attempt to delay/prevent Alzheimer's disease (AD).
-
The 'monoamine hypothesis' is insufficient in approaching the aetiology of psychiatric disorders or in developing novel therapies.
-
Kynurenine pathway (KP) activation is associated with many neuropsychiatric diseases, such as major depressive disorder (MDD) and Alzheimer's disease (AD).
-
The amyloid hypothesis suggests that the progressive accumulation and deposition of central nervous system (CNS) amyloid with aging is the proximate cause of Alzheimer's disease (AD).
-
The intersection of metabolic disease and neurodegeneration represents one of the most consequential frontiers in translational neuroscience.
From across this topic
10 of the 1,048 studies in this topic, picked by a fixed rule (a hash of each study's address), not by score or date; each page of this list shows a different 10. The same 10 appear here every time.
- Structural and Functional Dysbiosis of Fecal Microbiota in Chinese Patients With Alzheimer's Disease
- From revolution to evolution: the glutamate hypothesis of schizophrenia and its implication for treatment
- Geniposide, a novel agonist for GLP-1 receptor, prevents PC12 cells from oxidative damage via MAP kinase pathway
- Convergent Mitochondrial and Oxidative Stress Signatures in Spaceflight and Tauopathy: A Comparative Multi-Omics Reanalysis in Drosophila melanogaster
- Microbiome-gut-brain dysfunction in prodromal and symptomatic Lewy body diseases
- Mitochondrial abnormalities in Alzheimer's disease
- Hyperglycemia and Glycation in Diabetic Complications
- Protective properties of GLP-1 and associated peptide hormones in neurodegenerative disorders
- Glucagon-Like Peptide-1 Receptor Agonists and Brain Vascular Function
- Association between circadian rhythms and neurodegenerative diseases